These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. SPR-based fragment screening: advantages and applications. Neumann T; Junker HD; Schmidt K; Sekul R Curr Top Med Chem; 2007; 7(16):1630-42. PubMed ID: 17979772 [TBL] [Abstract][Full Text] [Related]
27. Selection criteria for drug-like compounds. Muegge I Med Res Rev; 2003 May; 23(3):302-21. PubMed ID: 12647312 [TBL] [Abstract][Full Text] [Related]
28. Affinity constants for small molecules from SPR competition experiments. de Mol NJ Methods Mol Biol; 2010; 627():101-11. PubMed ID: 20217616 [TBL] [Abstract][Full Text] [Related]
29. Rapid and label-free bacteria detection by surface plasmon resonance (SPR) biosensors. Dudak FC; Boyaci IH Biotechnol J; 2009 Jul; 4(7):1003-11. PubMed ID: 19288516 [TBL] [Abstract][Full Text] [Related]
30. SPR biosensor as a tool for screening prion protein binders as potential antiprion leads. Chen B Methods Mol Biol; 2010; 627():147-55. PubMed ID: 20217619 [TBL] [Abstract][Full Text] [Related]
31. Fragment-based lead discovery and design. Joseph-McCarthy D; Campbell AJ; Kern G; Moustakas D J Chem Inf Model; 2014 Mar; 54(3):693-704. PubMed ID: 24490951 [TBL] [Abstract][Full Text] [Related]
32. Biomolecular interactions by Surface Plasmon Resonance technology. Torreri P; Ceccarini M; Macioce P; Petrucci TC Ann Ist Super Sanita; 2005; 41(4):437-41. PubMed ID: 16569911 [TBL] [Abstract][Full Text] [Related]
33. Surface plasmon resonance biosensor for biomolecular interaction analysis based on spatial modulation phase detection. Ding X; Liu F; Yu X Methods Mol Biol; 2009; 503():21-35. PubMed ID: 19151934 [TBL] [Abstract][Full Text] [Related]
35. Time-resolved fluorescence resonance energy transfer and surface plasmon resonance-based assays for retinoid and transthyretin binding to retinol-binding protein 4. Sharif O; Hu H; Klock H; Hampton EN; Nigoghossian E; Knuth MW; Matzen J; Anderson P; Trager R; Uno T; Glynne RJ; Azarian SM; Caldwell JS; Brinker A Anal Biochem; 2009 Sep; 392(2):162-8. PubMed ID: 19482004 [TBL] [Abstract][Full Text] [Related]
36. Application of chromogenic reagents in surface plasmon resonance (SPR). Mavri J; Raspor P; Franko M Biosens Bioelectron; 2007 Jan; 22(6):1163-7. PubMed ID: 16930983 [TBL] [Abstract][Full Text] [Related]
37. Optimizing the hit-to-lead process using SPR analysis. Löfås S Assay Drug Dev Technol; 2004 Aug; 2(4):407-15. PubMed ID: 15357922 [TBL] [Abstract][Full Text] [Related]
39. Kinetic analysis and fragment screening with Fujifilm AP-3000. Rich RL; Myszka DG Anal Biochem; 2010 Jul; 402(2):170-8. PubMed ID: 20371220 [TBL] [Abstract][Full Text] [Related]
40. Cell-impedance-based label-free technology for the identification of new drugs. Lundstrom K Expert Opin Drug Discov; 2017 Apr; 12(4):335-343. PubMed ID: 28276704 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]